Business
CBDL's Recent Additions to Active Sales Channels Fuel 18-Month Sales Projections; CBD Vault(TM) Products' Projected 2025 Sales Revenues to Reach $1.8 Million
CBDL's Recent Additions to Active Sales Channels Fuel 18-Month Sales Projections; CBD Vault(TM) Products' Projected 2025 Sales Revenues to Reach $1.8 Million.
About this update from Cbd Life Sciences Inc.
[{"type":"text","content":"SCOTTSDALE, AZ / ACCESSWIRE / July 24, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The CBD Vault Inc., a leading innovator in the CBD industry, has announced that it increased its revenue projection for 2025 to $1.8 million on the strength of its recently launched CBD VaultTM brand sales. The forecast increase is based both on anticipated organic growth and expected revenue contribution from recently added sales channel partners, as well as rapidly developing opportunities to establish operating partnerships on a more national scale."As we keep saying, we are extremely pleased with the reception of our CBD VaultTM brand in the way that it has gained us traction towards establishing greater visibility in the highly competitive CBD products market," said Lisa Nelson, CEO of CBDL. "We are committed to leveraging this greater visibility into ever-stronger sales channel partners that, in turn, will drive us to our future sales objectives."About The CBD Vault Inc. and CBD Life Sciences, Inc.The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets. The CBD Vault's products can be viewed and purchased on the Company's website at www.thecbdvault.comFollow our social media for the latest updates!X: https://www.x.com/CBDL_StockOTCInstagram: https://www.instagram.com/cbd.vaultIR Contact: [email protected] StatementsExcept for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.Safe Harbor StatementThis release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertaintie...